DEA
ACH

DoubleLine ETF Adviser’s Accendra Health ACH Stock Holding History

DoubleLine ETF Adviser’s Portfolio ACH Stock Details ACH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-24,287
Closed -$55.4K – 204
2026
Q1 		$55.4K Buy
24,287
+7,498
+45% +$17.3K 0.02% 173
2025
Q4 		$47K Buy
+16,789
New +$60K 0.01% 165

Other funds holding ACH

CCM
Coliseum Capital Management Rowayton, Connecticut $1.16B AUM 23.26% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $1.67B AUM 1.43% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $3.67B AUM 121.12% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

DoubleLine ETF Adviser's ACH Position: Q2 2026 in Review

DoubleLine ETF Adviser sold out of Accendra Health (ACH) in Q2 2026, closing a stake of 24,287 shares — an estimated $55.4K sold.

DoubleLine ETF Adviser first reported a position in ACH in Q4 2025 and held it in 2 quarters. The position peaked at $55.4K in Q1 2026. 139 funds tracked by Wall St. Rank hold ACH as of Q2 2026.

  • DoubleLine ETF Adviser reported no remaining Accendra Health position as of Q2 2026 after selling out during the quarter.
  • DoubleLine ETF Adviser sold 24,287 Accendra Health shares in Q2 2026, an estimated $55.4K.
  • DoubleLine ETF Adviser first reported a position in Accendra Health in Q4 2025 and held it in 2 quarters.
  • DoubleLine ETF Adviser's Accendra Health position peaked at $55.4K in Q1 2026.
  • 139 funds tracked by Wall St. Rank held Accendra Health as of Q2 2026.

Based on DoubleLine ETF Adviser's 13F filing for Q2 2026, filed 14 Aug 2026.